Company News /
by Lauren Evans -
2 years ago
29 Jun 2022 - A regulatory agency has approved Invex Therapeutics’ (ASX:IXC) authorisation to commence the IIH EVOLVE phase 3 clinical trial in the UK, for patients with idiopathic…
Market Reports /
by Melissa Darmawan -
2 years ago
29 Jun 2022 - The rout in Australian shares have continued to deepen in a broad-based sell-off led by interest rate sensitive sectors, including listed property and information tec…
Market Reports /
by Rachael Jones -
5 years ago
05 Jul 2019 - It has been a positive day of trade for the Australian share market. The local bourse managed to maintain momentum to gain 0.5%. Fortescue Metals Group’s Founder and …
Market Reports /
by Rachael Jones -
5 years ago
05 Jul 2019 - The ASX rose at the open and is now tracking 0.1% higher at noon. The Real Estate Investment Trust sector is leading the way and the Material sector trailing behind. …
